Gene expression in SK-Mel-28 human melanoma cells treated with the snake venom jararhagin

Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors

Andrew R. Reynolds, Ian R. Hart, Alan R. Watson et al. · Nature Medicine · 2009 · 478 citations

Medicine, Cancer Biology, Oncology +16

Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme

David A. Reardon, Karen Fink, Tom Mikkelsen et al. · Journal of Clinical Oncology · 2008 · 473 citations · Full text

Medicine, Oncology, Pharmacology +16

Purification, cloning, and molecular characterization of a high molecular weight hemorrhagic metalloprotease, jararhagin, from Bothrops jararaca venom. Insights into the disintegrin gene family

Mark J. I. Paine, H. Desmond, R.D.G. Theakston et al. · Journal of Biological Chemistry · 1992 · 327 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Phase I and Correlative Biology Study of Cilengitide in Patients With Recurrent Malignant Glioma

Burt Nabors, Tom Mikkelsen, Steven S. Rosenfeld et al. · Journal of Clinical Oncology · 2007 · 289 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Assessment of the biological and pharmacological effects of the ανβ3 and ανβ5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors

Seetharaman Hariharan, Daniel L. Gustafson, Scott N. Holden et al. · Annals of Oncology · 2007 · 127 citations

Medicine, Oncology, Pharmacology +16